[HTML][HTML] Updates and insights in the diagnosis and management of DRESS syndrome

EM Schunkert, SJ Divito - Current dermatology reports, 2021 - Springer
Abstract Purpose of Review To provide updates on recent advances in the diagnosis and
management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome …

[HTML][HTML] Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis

A Hasegawa, R Abe - F1000Research, 2020 - ncbi.nlm.nih.gov
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
diseases characterized by detachment of the epidermis and mucous membrane. SJS/TEN …

[HTML][HTML] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

C Kloypan, N Koomdee, P Satapornpong, T Tempark… - Pharmaceuticals, 2021 - mdpi.com
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …

[HTML][HTML] Drug reaction with eosinophilia and systemic symptoms (DReSS)/Drug-Induced hypersensitivity syndrome (DiHS)—readdressing the DReSS

H Stirton, NH Shear, RP Dodiuk-Gad - Biomedicines, 2022 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …

Modern developments in germline pharmacogenomics for oncology prescribing

NM Reizine, PH O'Donnell - CA: a cancer journal for clinicians, 2022 - Wiley Online Library
The integration of genomic data into personalized treatment planning has revolutionized
oncology care. Despite this, patients with cancer remain vulnerable to high rates of adverse …

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …

BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2023 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Returning incidental findings in African genomics research

A Wonkam, J de Vries - Nature Genetics, 2020 - nature.com
Returning incidental findings in African genomics research | Nature Genetics Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

[HTML][HTML] From pharmacogenetics to pharmaco-omics: Milestones and future directions

C Auwerx, MC Sadler, A Reymond, Z Kutalik - Human Genetics and …, 2022 - cell.com
The origins of pharmacogenetics date back to the 1950s, when it was established that inter-
individual differences in drug response are partially determined by genetic factors. Since …

New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis

Y Saito, R Abe - Current Opinion in Allergy and Clinical …, 2023 - journals.lww.com
The pathogenesis of SJS/TEN remains unclear and effective therapeutic agents have not yet
been established. As the involvement of innate immunity, such as monocytes and …

[HTML][HTML] Tools for etiologic diagnosis of drug-induced allergic conditions

R Rodríguez-Pérez, L de Las Vecillas… - International Journal of …, 2023 - mdpi.com
Drug hypersensitivity reactions are a serious concern in clinical practice because they can
be severe and result in lifelong sequelae. An accurate diagnosis and identification of the …